Close Menu
New York Examiner News

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Art Garfunkel Says He’s Considering Leaving US Over Trump Presidency

    September 6, 2026

    Trump asks the Supreme Court a third time to limit mail-in ballots

    September 6, 2026

    Jamie Raskin Warns That Trump Is Trying To Steal The Midterms Right Now

    September 6, 2026
    Facebook X (Twitter) Instagram
    New York Examiner News
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • Lifestyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Terms and Conditions
      • Privacy Policy
    New York Examiner News
    Home»Business»Biden has tested positive for COVID yet again in case of Paxlovid rebound
    Business

    Biden has tested positive for COVID yet again in case of Paxlovid rebound

    By AdminJuly 30, 2022
    Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Biden has tested positive for COVID yet again in case of Paxlovid rebound



    U.S. President Joe Biden has tested positive for COVID yet again—after taking Paxlovid—in what a White House physician Saturday called a case of “rebound.”

    Biden—who initially tested positive July 21, after a week of traveling across the Middle East—tested negative for the virus on Tuesday night and again on Wednesday morning of this past week, when he ended his isolation.

    He additionally tested negative Thursday and Friday mornings before testing positive again Saturday morning, according to a letter from presidential physician Dr. Kevin O’Connor to White House Press Secretary Karine Jean-Pierre, obtained and posted to Twitter by a Reuters correspondent.

    On Saturday the president said via Twitter that he would return to isolation despite the fact that he’s not experiencing new symptoms.

    “Folks, today I tested positive for COVID again,” he wrote. “I’ve got no symptoms, but I am going to isolate for the safety of everyone around me. I’m still at work, and will be back on the road soon.”

    Folks, today I tested positive for COVID again.

    This happens with a small minority of folks.

    I’ve got no symptoms but I am going to isolate for the safety of everyone around me.

    I’m still at work, and will be back on the road soon.

    — President Biden (@POTUS) July 30, 2022

    What is Paxlovid?

    The president was treated with the COVID-19 antiviral Paxlovid the day he was diagnosed, according to multiple news outlets. It’s a pill approved for treatment of COVID-19 in high-risk adults and has emergency-use authorization from the U.S. Food and Drug Administration.

    But the drug is known for “rebound” cases, referred to by the U.S. Centers for Disease Control and Prevention as “a brief return of symptoms.”

    When diagnosed with COVID in June, chief presidential medical adviser Dr. Anthony Fauci was prescribed the antiviral due to his advanced age, which put him at greater risk for a severe outcome from COVID, despite being fully vaccinated and twice boosted.

    Fauci later said he had experienced a Paxlovid rebound.

    “After I finished the five days of Paxlovid, I reverted to negative on an antigen test for three days in a row,” Fauci, 81, said during an event at Foreign Policy’s Global Health Forum, Bloomberg reported. “And then on the fourth day, just to be absolutely certain, I tested myself again.”

    “I reverted back to positive,” he said. 

    Fauci later told the New York Times that Paxlovid kept him out of the hospital and stopped his infection from becoming more severe initially, saying, “Paxlovid did what it was supposed to do.”

    Fauci began a second course of Paxlovid when symptoms emerged “much worse than the first go-around,” he said. In May the CDC issued a health advisory about such rebounds, saying there was no evidence that additional treatment is needed for rebound cases. It is unclear why Fauci apparently acted against CDC advice.

    In June, Pfizer, which manufactures Paxlovid, announced that it would stop adding new participants to a trial of the drug among COVID patients at low risk of hospitalization and death. The study failed to demonstrate that the drug reduced symptoms, or hospitalizations and deaths in a statistically significant way, according to Bloomberg.

    How long to quarantine?

    The CDC currently advises COVID-positive individuals to quarantine for five days before returning to normal life (and masking in public for an additional five days). The recommended isolation time was 10 days until December, when the federal health agency halved its recommendation.

    But “there is not data to support five days or anything shorter than 10 days,” Amy Barczak, a physician at the Massachusetts General Hospital Infectious Disease Division, recently told Nature.

    Scientists have questioned the scientific rationale behind the policy since the CDC introduced it late last year. And now critics have more data to back up their claims: Viral shedding can occur beyond 10 days in even healthy, vaccinated adults, according to a preprint out of London published this month.

    Some scientists advise that people should stop quarantining only once they test negative using at-home tests, rather than relying on the CDC’s five-day rule.

    Biden did so, however, testing negative at five and then six days after infection before ending his quarantine, during which he worked from home. The White House had said that Biden would go “above and beyond” the CDC’s five-day guidance and wait until he tested negative before returning to public life.

    Sign up for the Fortune Features email list so you don’t miss our biggest features, exclusive interviews, and investigations.





    Original Source Link

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Previous ArticleWar: Trump To Sue CNN For ‘Repeated Defamatory Statements’
    Next Article Why Max Cavalera Thinks Sepultura’s ‘Roots’ Was Labeled Nu-Metal

    RELATED POSTS

    Trump asks the Supreme Court a third time to limit mail-in ballots

    September 6, 2026

    ASEAN can still hedge between America and China on AI. It needs to get its act together first

    September 6, 2026

    U.S. sanctions Turkish bank, accusing it of helping Iran transfer oil revenue from China to Turkey

    September 5, 2026

    OpenAI quietly boosts some of Astra’s evaluation metrics, and continues to change others post-launch

    September 5, 2026

    Josh Kushner: Thrive would have stayed away from World Cup deal if it had known what was coming

    September 4, 2026

    GAO finds Secret Service left drone threats unaddressed before Trump assassination attempt

    September 4, 2026
    latest posts

    Art Garfunkel Says He’s Considering Leaving US Over Trump Presidency

    Art Garfunkel has famously spent years taking long-distance walks across the United States, Japan, and…

    Trump asks the Supreme Court a third time to limit mail-in ballots

    September 6, 2026

    Jamie Raskin Warns That Trump Is Trying To Steal The Midterms Right Now

    September 6, 2026

    West Virginia angler lands 72.75-pound blue catfish to set new state record on the Ohio River

    September 6, 2026

    TechCrunch Mobility: Tesla Cybercab hits the road — and a snag

    September 6, 2026

    These Cyborg Cockroaches Could Save Your Life

    September 6, 2026

    Queer Edward II – first-look review

    September 6, 2026
    Categories
    • Books (1,474)
    • Business (6,377)
    • Events (72)
    • Film (6,312)
    • Lifestyle (4,385)
    • Music (6,440)
    • Politics (6,363)
    • Science (5,729)
    • Technology (6,310)
    • Television (6,000)
    • Uncategorized (9)
    • US News (6,365)
    popular posts

    Workin Moms Renewed, Ending With Final Season 7 — 2023 Netflix Release

    The Workin’ Moms are clockin’ out. The popular Canadian comedy, which streams Stateside on Netflix,…

    Danish Artist Fights Ruling To Repay Cash For Empty Frames

    September 27, 2023

    The N1 Deck Jacket: How This Bad Boy Killed the Peacoat

    January 4, 2026

    The Workers Who Make Your Clothes Want Higher Pay. Who Should Pony Up? 

    November 8, 2023
    Archives
    Browse By Category
    • Books (1,474)
    • Business (6,377)
    • Events (72)
    • Film (6,312)
    • Lifestyle (4,385)
    • Music (6,440)
    • Politics (6,363)
    • Science (5,729)
    • Technology (6,310)
    • Television (6,000)
    • Uncategorized (9)
    • US News (6,365)
    About Us

    We are a creativity led international team with a digital soul. Our work is a custom built by the storytellers and strategists with a flair for exploiting the latest advancements in media and technology.

    Most of all, we stand behind our ideas and believe in creativity as the most powerful force in business.

    What makes us Different

    We care. We collaborate. We do great work. And we do it with a smile, because we’re pretty damn excited to do what we do. If you would like details on what else we can do visit out Contact page.

    Our Picks

    These Cyborg Cockroaches Could Save Your Life

    September 6, 2026

    Queer Edward II – first-look review

    September 6, 2026

    ‘Lioness’ Stars Break Down ‘Sugar Land’s Epic Crash, That Shocking Death, and More (Exclusive)

    September 6, 2026
    © 2026 New York Examiner News. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms & Conditions and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT